EC grants ‘conditional’ nod for Merck’s drug to treat VHL disease
HQ Team February 18, 2025: Merck and Co’s drug, for treating adult patients with kidney and pancreatic cancer, tumours and who had prior.
Drugs
Health
Medical
Drugs
Health
Medical
Vertex’s non-opioid painkiller receives approval from US drug regulator
Vertex Pharmaceuticals Inc.’s non-opioid analgesic to treat moderate to severe acute pain in adults got approval from the US drug regulator.
Drugs
Medical
Pharma
Pfizer’s drug to treat metastatic colorectal cancer gets US approval
fizer Inc.’s combination drug to treat a type of metastatic colorectal cancer has been approved by the US drug regulator, according to a.
Drugs
Medical
Pharma
AstraZeneca, Daiichi’s trial drug for lung cancer, gets US regulator’s nod
The US regulator has granted a breakthrough therapy designation to British-Swedish AstraZeneca and Japan’s Daiichi Sankyo experimental drug for treating a certain type.
Health
Uncategorized
EU regulators reverse course, approve Alzheimer’s drug Leqembi
HQ Team November 19, 2024: The European Medicines Agency (EMA) granted conditional approval for lecanemab, for the treatment of early Alzheimer’s disease in.
Drugs
Health
Pharma
FDA panel rejects Novo Nordisk’s weekly jab to treat type 1 diabetes
The Endocrinologic and Metabolic Drugs Advisory Committee of the FDA refused approval for a once-weekly jab to control blood sugar levels in people.
Drugs
Health
Pharma
US regulator clears Merck’s lung therapy after ‘significant’ results
HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to.
Drugs
Pharma
FDA approves Immunogen’s drug for advanced ovarian cancer
The Food and Drug Administration approved a new treatment for patients with advanced ovarian cancer — an antibody that delivers a targeted dose.